|
|
 |
Trial Data
Cogtest has a large normative and patient database and has shown pharmacosensitivity to various compounds, e.g. scopolamine, antidepressants, antipsychotics, and cognitive enhancers.
There are over 80 publications of individual tests in the Cogtest Library from worldwide data along with fMRI validation of some of the tests used in the library.
- Rivastigmine Augmentation of
Novel Antipsychotics (APDs) in Schizophrenia - Presented at Davos
Schizophrenia meeting, 2004
- Lundbeck/Solvay/Wyeth Buprefenox
- PR Newswire release, 2004
- Janssen Risperidone Consta - Presentation at Davos
Schizophrenia meeting, 2004
- AstraZeneca Seroquel vs Risperidone in Schizophrenia
- Poster presentation at CINP Paris, 2004
- Lilly First Episode Study (CPT-IP)
- Published by Am J Psych, May 2004
- Cognitive Enhancement in Schizophrenia with Alpha7
Agonists
- Cognitive Enhancement in Schizophrenia with
Inverse Agonist and Competitive Antagonist of the 5HT2A
Receptor
- Randomized Trial of APDs in Treatment of
Naïve First Episode Schizophrenia
- Adjunctive Treatment of Schizophrenia and
Bipolar Disorder with Glycine, D-cycloserine, L-carnosine
- Effects of Nicotinic Agonist on
Cognitive Function in Schizophrenia
- Effects of Ability on Cognitive
Function in First Episode Schizophrenia
- Cognitive Effects of Atomoxetine in
Schizophrenia
|
: